MEDIROM Healthcare Technologies (MRM) Competitors $1.56 -0.13 (-7.69%) Closing price 04:00 PM EasternExtended Trading$1.58 +0.02 (+1.28%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MRM vs. IH, CHGG, STG, NAMI, AACG, YSXT, BEDU, HCMA, KIDZ, and KUKEShould you be buying MEDIROM Healthcare Technologies stock or one of its competitors? The main competitors of MEDIROM Healthcare Technologies include iHuman (IH), Chegg (CHGG), Sunlands Technology Group (STG), NAMI (NAMI), ATA (AACG), YSX Tech (YSXT), Bright Scholar Education (BEDU), HCM Acquisition (HCMA), Classover (KIDZ), and Kuke Music (KUKE). These companies are all part of the "personal services" industry. MEDIROM Healthcare Technologies vs. Its Competitors iHuman Chegg Sunlands Technology Group NAMI ATA YSX Tech Bright Scholar Education HCM Acquisition Classover Kuke Music MEDIROM Healthcare Technologies (NYSE:MRM) and iHuman (NYSE:IH) are both small-cap personal services companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Do institutionals and insiders believe in MRM or IH? 4.9% of iHuman shares are held by institutional investors. 40.2% of MEDIROM Healthcare Technologies shares are held by insiders. Comparatively, 63.6% of iHuman shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is MRM or IH more profitable? iHuman has a net margin of 12.46% compared to MEDIROM Healthcare Technologies' net margin of 0.00%. iHuman's return on equity of 11.59% beat MEDIROM Healthcare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets MEDIROM Healthcare TechnologiesN/A N/A N/A iHuman 12.46%11.59%7.93% Do analysts prefer MRM or IH? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MEDIROM Healthcare Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00iHuman 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor MRM or IH? In the previous week, MEDIROM Healthcare Technologies and MEDIROM Healthcare Technologies both had 6 articles in the media. MEDIROM Healthcare Technologies' average media sentiment score of 0.96 beat iHuman's score of 0.79 indicating that MEDIROM Healthcare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MEDIROM Healthcare Technologies 2 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iHuman 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, MRM or IH? MEDIROM Healthcare Technologies has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, iHuman has a beta of 0.39, meaning that its share price is 61% less volatile than the S&P 500. Which has higher earnings and valuation, MRM or IH? iHuman has lower revenue, but higher earnings than MEDIROM Healthcare Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMEDIROM Healthcare Technologies$8.30B0.01$820KN/AN/AiHuman$126.34M1.16$13.51M$0.299.71 SummaryiHuman beats MEDIROM Healthcare Technologies on 7 of the 12 factors compared between the two stocks. Get MEDIROM Healthcare Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRM vs. The Competition Export to ExcelMetricMEDIROM Healthcare TechnologiesPersonal services IndustryMedical SectorNYSE ExchangeMarket Cap$44.28M$759.42M$5.77B$21.70BDividend YieldN/A2.46%5.68%3.52%P/E RatioN/A2,139.7257.3827.15Price / Sales0.0145.29551.9360.37Price / Cash1.4945.3737.5624.47Price / Book5.032.9413.184.56Net Income$820K$39.59M$3.29B$1.00B7 Day Performance-15.68%-1.34%2.50%0.38%1 Month Performance-11.86%6.75%4.60%2.42%1 Year Performance-56.55%200.69%73.81%13.77% MEDIROM Healthcare Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRMMEDIROM Healthcare Technologies0.5881 of 5 stars$1.56-7.7%N/A-56.2%$44.28M$8.30B0.00480Positive NewsIHiHuman1.9218 of 5 stars$2.98-2.5%N/A+70.6%$154.70M$897.64M11.011,120Earnings ReportUpcoming EarningsGap UpCHGGChegg2.7568 of 5 stars$1.39-1.8%$1.70+22.7%-0.6%$147.87M$617.57M-0.521,271Gap UpSTGSunlands Technology Group0.6356 of 5 stars$8.23-6.7%N/A+23.8%$111.17M$2.00B2.282,071NAMINAMIN/A$1.10-0.9%N/AN/A$86.98M$406.40M0.00N/AAACGATA0.5122 of 5 stars$2.27+4.4%N/A+222.6%$72.28M$36.72M-22.65580Positive NewsYSXTYSX TechN/A$3.15+19.8%N/AN/A$70.12MN/A0.0040Gap UpHigh Trading VolumeBEDUBright Scholar Education1.4147 of 5 stars$1.81-1.1%N/A-7.3%$52.91M$175.19M-0.382,193Positive NewsGap DownHCMAHCM AcquisitionN/A$3.250.0%N/A-30.3%$45.96MN/A0.00N/ANews CoverageKIDZClassoverN/A$1.41-4.6%N/AN/A$33.43MN/A0.00N/AKUKEKuke MusicN/A$1.61+1.9%N/A-82.0%$32.72M$9.59M0.00170Gap Down Related Companies and Tools Related Companies iHuman Competitors Chegg Competitors Sunlands Technology Group Competitors NAMI Competitors ATA Competitors YSX Tech Competitors Bright Scholar Education Competitors HCM Acquisition Competitors Classover Competitors Kuke Music Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MRM) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEDIROM Healthcare Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEDIROM Healthcare Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.